AJP - Endo Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (September 30, 2003). doi:10.1152/ajpendo.00343.2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/2/E226    most recent
00343.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moore, M. C.
Right arrow Articles by Cherrington, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moore, M. C.
Right arrow Articles by Cherrington, A. D.
Submitted on July 28, 2003
Accepted on September 29, 2003

Unlike Mice, Dogs Exhibit Effective Glucoregulation During Low-Dose Portal and Peripheral Glucose Infusion

Mary Courtney Moore1*, Sylvain Cardin1, Dale S. Edgerton2, Ben Farmer1, Doss W. Neal1, Margaret Lautz1, and Alan D. Cherrington1

1 Department of Molecular Physiology & Biophysics and Diabetes Research & Training Center, Vanderbilt University School of Medicine, Nashville, TN, USA
2 Department of Molecular Physiology & Biophysics and Diabetes Research & Training Center, Vanderbilt University School of Medicine, Nashville, TN, USA; Wellstat Therapeutics, Gaithersburg, MD, USA

* To whom correspondence should be addressed. E-mail: genie.moore{at}vanderbilt.edu.

Portal infusion of glucose in the mouse at a rate equivalent to basal endogenous glucose production causes hypoglycemia, while peripheral infusion at the same rate causes significant hyperglycemia. We used tracer and arteriovenous difference techniques in conscious 42-h-fasted dogs to determine their response to the same treatments. The studies consisted of 3 periods: equilibration (100 min), basal (40 min), and experimental (180 min), during which glucose was infused at 13.7 µmol.kg-1.min-1 into a peripheral (PE, n=5) or the hepatic portal (PO, n=5) vein. Arterial blood glucose increased ~0.8 mmol/l in both groups. Arterial and hepatic sinusoidal insulin concentrations were not significantly different between groups. PE exhibited an increase in nonhepatic glucose uptake (non-HGU; {Delta}8.6±1.2 µmol.kg-1.min-1) within 30 min, whereas PO showed a slight suppression ({Delta}-3.7±3.1 µmol.kg-1.min-1). PO shifted from net hepatic glucose output (NHGO) to uptake (NHGU; 2.5±2.8 µmol.kg-1.min-1) within 30 min, but PE still exhibited NHGO (6.0±1.9 µmol.kg-1.min-1) at that time and did not initiate NHGU until after 90 min. Glucose Ra and Rd did not differ between groups. The response to the two infusion routes was markedly different. Peripheral infusion caused a rapid enhancement of non-HGU, while portal delivery quickly activated NHGU. As a result, both groups maintained near-euglycemia. The dog glucoregulates more rigorously than the mouse in response to both portal and peripheral glucose delivery.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. J. Winnick, Z. An, M. C. Moore, C. J. Ramnanan, B. Farmer, M. Shiota, and A. D. Cherrington
A physiological increase in the hepatic glycogen level does not affect the response of net hepatic glucose uptake to insulin
Am J Physiol Endocrinol Metab, August 1, 2009; 297(2): E358 - E366.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Rossetti, F. Porcellati, P. Lucidi, N. Busciantella Ricci, P. Candeloro, P. Cioli, F. Santeusanio, G. B. Bolli, and C. G. Fanelli
Portal Vein Glucose Sensors Do Not Play a Major Role in Modulating Physiological Responses to Insulin-Induced Hypoglycemia in Humans
Diabetes, January 1, 2009; 58(1): 194 - 202.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. C. Ertl, S. Mann, A. Richardson, V. J. Briscoe, H. B. Blair, D. B. Tate, and S. N. Davis
Effects of oral carbohydrate on autonomic nervous system counterregulatory responses during hyperinsulinemic hypoglycemia and euglycemia
Am J Physiol Endocrinol Metab, September 1, 2008; 295(3): E618 - E625.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. M. S. Johnson, D. S. Edgerton, T. Rodewald, M. Scott, B. Farmer, D. Neal, and A. D. Cherrington
Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E1085 - E1091.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F.-Y. Chueh, C. Malabanan, and O. P. McGuinness
Impact of portal glucose delivery on glucose metabolism in conscious, unrestrained mice
Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1206 - E1211.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. A. DiCostanzo, D. P. Dardevet, D. W. Neal, M. Lautz, E. Allen, W. Snead, and A. D. Cherrington
Role of the hepatic sympathetic nerves in the regulation of net hepatic glucose uptake and the mediation of the portal glucose signal
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E9 - E16.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. Ogihara, W. Kawamura, K. Kasuga, Y. Hayashi, H. Arakawa, and M. Kikuchi
Characterization of the portal signal during 24-h glucose delivery in unrestrained, conscious rats
Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E932 - E940.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.